Neurodegeneration cell per cell.

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Clinical definitions of neurodegenerative diseases focus on late-stage symptoms, overlooking early cellular processes.
• Slowly progressing, clinically silent multicellular events precede circuitry failures and protein aggregation (Aβ, Tau, TDP-43, α-synuclein).

Purpose of the Study:

• To highlight the importance of studying the early cellular phase of neurodegenerative disorders.
• To emphasize how new technologies can revolutionize the understanding and treatment of these diseases.

Main Methods:

• Leveraging advances in single-cell omics technologies.
• Utilizing complex genetics and induced pluripotent stem (iPS) cell models.
• Analyzing complex cellular interactions in early disease stages.

Main Results:

• Early cellular and multicellular processes are key initiators or triggers in neurodegeneration.
• Current research is shifting focus towards the preclinical, cellular stages of disease.
• Technological advancements enable detailed analysis of these early, silent phases.

Conclusions:

• Understanding early cellular changes is crucial for redefining neurodegenerative disease progression.
• Novel diagnostics and cell-specific therapeutics can be developed by targeting these initial stages.
• Intervention during the early cellular phase offers potential to prevent irreversible brain damage.